191 related articles for article (PubMed ID: 16473506)
1. Point-of-care biosensor systems for cancer diagnostics/prognostics.
Soper SA; Brown K; Ellington A; Frazier B; Garcia-Manero G; Gau V; Gutman SI; Hayes DF; Korte B; Landers JL; Larson D; Ligler F; Majumdar A; Mascini M; Nolte D; Rosenzweig Z; Wang J; Wilson D
Biosens Bioelectron; 2006 Apr; 21(10):1932-42. PubMed ID: 16473506
[TBL] [Abstract][Full Text] [Related]
2. Electrochemical biosensors: towards point-of-care cancer diagnostics.
Wang J
Biosens Bioelectron; 2006 Apr; 21(10):1887-92. PubMed ID: 16330202
[TBL] [Abstract][Full Text] [Related]
3. Development of biosensors for cancer clinical testing.
Rasooly A; Jacobson J
Biosens Bioelectron; 2006 Apr; 21(10):1851-8. PubMed ID: 16458498
[TBL] [Abstract][Full Text] [Related]
4. Biosensors for cancer markers diagnosis.
Tothill IE
Semin Cell Dev Biol; 2009 Feb; 20(1):55-62. PubMed ID: 19429492
[TBL] [Abstract][Full Text] [Related]
5. [Current bioanalytic techniques in the laboratory diagnosis and in the monitoring of treatment outcome in oncologic diseases].
Ovchinnikov IV
Vopr Onkol; 2003; 49(5):555-62. PubMed ID: 14682125
[No Abstract] [Full Text] [Related]
6. Nucleic acid based biosensors: the desires of the user.
Hahn S; Mergenthaler S; Zimmermann B; Holzgreve W
Bioelectrochemistry; 2005 Oct; 67(2):151-4. PubMed ID: 16019267
[TBL] [Abstract][Full Text] [Related]
7. Biomarker profiling for cancer diagnosis, prognosis and therapeutic management.
Mitra AP; Lin H; Cote RJ; Datar RH
Natl Med J India; 2005; 18(6):304-12. PubMed ID: 16483031
[TBL] [Abstract][Full Text] [Related]
8. [Molecular markers having a prognostic or therapeutic value in cancer].
Brousset P
Ann Pathol; 2008 Nov; 28 Spec No 1(1):S69-70. PubMed ID: 18984307
[No Abstract] [Full Text] [Related]
9. Moving cancer diagnostics from bench to bedside.
Zhang X; Li L; Wei D; Yap Y; Chen F
Trends Biotechnol; 2007 Apr; 25(4):166-73. PubMed ID: 17316853
[TBL] [Abstract][Full Text] [Related]
10. [Predicting response to therapy in breast cancer].
Strunz K; Deissler H; Kreienberg R; Sauer G
Gynakol Geburtshilfliche Rundsch; 2008; 48(3):113-7. PubMed ID: 18566527
[TBL] [Abstract][Full Text] [Related]
11. New generation of molecular prognostic and predictive tests for breast cancer.
Pusztai L; Cristofanilli M; Paik S
Semin Oncol; 2007 Apr; 34(2 Suppl 3):S10-6. PubMed ID: 17512431
[TBL] [Abstract][Full Text] [Related]
12. Affinity biosensors for tumor-marker analysis.
Palchetti I
Bioanalysis; 2014; 6(24):3417-35. PubMed ID: 25534795
[TBL] [Abstract][Full Text] [Related]
13. Multiple biomarkers in molecular oncology. II. Molecular diagnostics applications in breast cancer management.
Malinowski DP
Expert Rev Mol Diagn; 2007 May; 7(3):269-80. PubMed ID: 17489734
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profiling of non-small-cell lung cancer.
Lacroix L; Commo F; Soria JC
Expert Rev Mol Diagn; 2008 Mar; 8(2):167-78. PubMed ID: 18366303
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.
Rody A; Karn T; Gätje R; Kourtis K; Minckwitz G; Loibl S; Munnes M; Ruckhäberle E; Holtrich U; Kaufmann M; Ahr A
Zentralbl Gynakol; 2006 Apr; 128(2):76-81. PubMed ID: 16673249
[TBL] [Abstract][Full Text] [Related]
16. Mass spectrometry-based "omics" technologies in cancer diagnostics.
Zhang X; Wei D; Yap Y; Li L; Guo S; Chen F
Mass Spectrom Rev; 2007; 26(3):403-31. PubMed ID: 17405143
[TBL] [Abstract][Full Text] [Related]
17. Strategies for discovering novel cancer biomarkers through utilization of emerging technologies.
Kulasingam V; Diamandis EP
Nat Clin Pract Oncol; 2008 Oct; 5(10):588-99. PubMed ID: 18695711
[TBL] [Abstract][Full Text] [Related]
18. Methods and biomarkers for the diagnosis and prognosis of cancer and other diseases: towards personalized medicine.
Anderson JE; Hansen LL; Mooren FC; Post M; Hug H; Zuse A; Los M
Drug Resist Updat; 2006; 9(4-5):198-210. PubMed ID: 17011811
[TBL] [Abstract][Full Text] [Related]
19. A comparative study of the cytoskeleton binding drugs nocodazole and taxol with a mammalian cell quartz crystal microbalance biosensor: different dynamic responses and energy dissipation effects.
Marx KA; Zhou T; Montrone A; McIntosh D; Braunhut SJ
Anal Biochem; 2007 Feb; 361(1):77-92. PubMed ID: 17161375
[TBL] [Abstract][Full Text] [Related]
20. Miniaturized PCR systems for cancer diagnosis.
Day PJ
Biochem Soc Trans; 2009 Apr; 37(Pt 2):424-6. PubMed ID: 19290874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
